South Niagara Hospital Construction Updates and July Newsletter - Niagara Health
This story deserves to be shared
Send it to someone who'd care, or post it on your networks.
This article is an excerpt. To read the full content, visit the original source. Niagara Health
Related articles

Public Health Newsletter – Fall 2026 - College of Veterinary Medicine | Washington State University
It’s Fall Semester, and we’re back! What an exciting time for students, faculty, and staff. As we return to the hustle and bustle amid chilly mornings and a landscape of glorious gold and crimson leaves, it’s the perfect time to reflect on the spring and summer accomplishments of the College of Veterinary Medicine’s Public Health community. Dr. Allick continued to build connections across teaching, research, mentorship, and community engagement for the Washington State University (WSU) Public Health Program. Two undergraduates engaged actively in research, including a former Public Health 101 student Riley Sharp (now an undergraduate researcher collaborating with Dr. Allick) who developed a project on college students’ knowledge and perceptions of dementia and aging, and another, Leah Grier, who explored disability access while completing a summer internship at Seattle Children’s.
WHO São Tomé and Príncipe Newsletter for the 2nd Quarter - April to June 2026 - WHO | Regional Office for Africa

Bioengineer.org | Viral blips during HIV therapy are common and rarely signal treatment failure, Swedish study finds - European AIDS Treatment Group
Bioengineer.org news storyFor people living with HIV, modern antiretroviral therapy can suppress the virus to levels below what standard laboratory tests can detect. Yet some patients on long-term treatment experience a curious phenomenon: a single test result showing a small, transient amount of virus in the blood, followed by an immediate return to undetectable levels. These events, known as viral blips, have puzzled clinicians and researchers for years, raising questions about whether they represent harmless statistical noise, brief bursts of viral production from hidden reservoirs, or early warnings of impending treatment failure. A new nationwide Swedish study, published in BMC Infectious Diseases, offers one of the most comprehensive answers to date. Drawing on the Swedish national InfCareHIV cohort, researchers analyzed data from 4,210 treatment-naïve adults who began antiretroviral therapy from 1 January 2007 onward, with follow-up data extracted through 30 September 2020. The median observation time was 5.5 years, with some individuals followed for as long as 13.7 years.
0 comments
No comments yet. Be the first to share your thoughts!